Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends
Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends
TUESDAY, April 5 (HealthDay News) — In the latest analysis from the Women’s Health Initiative (WHI) study, researchers report that risks to postmenopausal women who were taking estrogen-only hormone therapy faded rapidly after they ended the treatment.
Read more on BusinessWeek
Categories: Breast Cancer Information Tags: after, Ends, estrogen, Fade, Hormone, Risks, Seen, Therapy, Treatment
You Docs: There’s still a good chance that hormone therapy can help you
You Docs: There’s still a good chance that hormone therapy can help you
What are the newer, safer forms? Bioidentical estrogen (estradiol) and micronized progesterone, which doesn’t block estrogen’s artery-pampering effects.
Read more on The Oregonian
Ending hormone therapy doesn’t cut breast-cancer risk, study says
Ending hormone therapy doesn’t cut breast-cancer risk, study says
Estrogen-plus-progestin hormone replacement therapy increases the risk of breast cancer in postmenopausal women. Now, a longer-term study of the problem shows the higher risk of breast cancer continues among women who took hormones but stopped, that the cancer in these women may be more advanced and that the likelihood of dying of breast cancer is increased.
Read more on Seattle Times
Categories: Breast Cancer Risks Tags: breastcancer, doesn't, ending, Hormone, Risk, says, Study, Therapy
Hormone therapy linked to more aggressive, deadlier breast cancers
Hormone therapy linked to more aggressive, deadlier breast cancers
Latest results from the Women’s Health Initiative, which included thousands of San Antonio women, finds the news about hormone treatment even bleaker than before.
Read more on San Antonio Express-News
Categories: Breast Cancer Questions & Answers Tags: aggressive, breast, cancers, deadlier, Hormone, Linked, more, Therapy
Hormone shot to fight breast cancer
Hormone shot to fight breast cancer
A Rs-75 injection increases the chances of survival for patients of breast cancer, a study conducted by the Tata Memorial Centre, Parel, has found. The cancer research institute carried out the study over a period of 12 years, involving 1,000 patients.
Read more on Hindustan Times
Ghostwritten articles overstate benefits of hormone replacement therapy and downplay harms
Ghostwritten articles overstate benefits of hormone replacement therapy and downplay harms
The first academic analysis of the 1500 documents unsealed in recent litigation against the pharmaceutical giant Wyeth (now part of Pfizer) reveals unprecedented insights into how pharmaceutical companies use ghostwriters to insert marketing messages into articles published in medical journals.
Read more on PhysOrg
Categories: Breast Cancer Risks Tags: articles, Benefits, downplay, Ghostwritten, harms, Hormone, overstate, replacement, Therapy
Cancer And Hormone Use
There is some good news to report in the battle against breast cancer. Breast cancer is the most common major cancer that affects women in North America and the second leading cause of cancer deaths in women worldwide. There are well over 1 million new cases reported every year, with over 210,000 in the U.S. alone. AFter many years of significant increases in breast cancer tumors having been reported, there may be some new hope.
An announcment at a recent Breast Cancer Symposium has reported that there may be a link between hormone use and breast cancer. Although they stopped short of declaring a definative link between the two, there was startling evidence that there is a connection.
During 2003, many women stopped taking menopauise hormones when a study showed that the hormones were raising the risk of cancer tumors. Since then, many women who had discovered tumors while undertaking hormone therapy prior, and then stopped, were found to be free of tumers. So, while the evidence is not compolete, there is great optimism that the link may have been found.
The reason there can not be a definite connection announced is that since tumors in the breast take so long to develop, going off the hormones would not necessarily prenvent new tumors. But for many women, those tumors that had been there before disontinuing the therapy noticed that the tumors had either disappeared, shrunk, or at least stopped growing.
The tumors were most evident among women aged 50 or over and particularly for tumors whose growth is fueled by estrogen. It is in this age group that the majority of hormone useage occourred.
Another bit of interesting data is that this drop in tumors was noticed by numerous registries that report cases to the federal government. Therefore, there is virtually no chance that the data is the result of some kind of fluke or error. Obviously, research is continuing to be sure that these results were not the result of some other factors. Plus, there is no evidence either way whether these tumors will continue to shrink and regress or just take longer to show up.
While this news is good and hopeful it is not definative. Other factors such as overall health, diet, smoking, and weight can still affect your chances of developing cancer. You show be aware of all of these things. But, for now, let’s rejoice in this good news.
Yvonne Volante, the author, is a big fan of good health practices and writes for fluidvitamin.com, which is the premier health and wellness resource on the internet. You can see all of the articles over at http://www.fluidvitamin.com
Categories: Breast Cancer Tumor Tags: cancer, Hormone
In Hormone Replacement Therapy, Breast Cancer Risk Varies Among Different Progestins Used,
In Hormone Replacement Therapy, Breast Cancer Risk Varies Among Different Progestins Used,
Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and …
Read more on Medical News Today
Categories: Breast Cancer Tumor Tags: among, breast, cancer, Different, Hormone, Progestins, replacement, Risk, Therapy, Used, Varies
Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010
Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010
The Endocrine Society presented its Scientific Statement on menopausal hormone therapy Monday in San Diego, Calif. at ENDO 2010: The 92nd Annual Meeting & Expo.
Read more on News-Medical-Net
Categories: Breast Cancer Risks Tags: 2010, ENDO, Endocrine, Hormone, Menopausal, presents, Scientific, society, Statement, Therapy
Supreme Court Denies Wyeth’s Request For New Trial In Hormone Replacement Therapy Case
Supreme Court Denies Wyeth’s Request For New Trial In Hormone Replacement Therapy Case
The Supreme Court on Monday denied Wyeth Pharmaceuticals’ request for a completely new trial of a lawsuit that claimed the drugmaker’s hormone replacement therapy drugs led to the plaintiff’s breast cancer, the Wall Street Journal reports. The court let stand a lower court’s 2009 ruling that said Wyeth is entitled to a partial retrial to assess punitive damages awarded to plaintiff Donna …
Read more on Medical News Today